PEG

Business Exit Planning Expert Laurie Barkman: Who Should Buy Your Business

Retrieved on: 
Tuesday, May 16, 2023
IPO, Making It! Minority Success Stories, Business, MBO, PEG, Barkman, Sale, Thought, Organization, Entrepreneurship, Acquisition, Essendon, Victoria, Investment, Family, Sales, Security (finance), Financial services

In her new book, The Business Transition Handbook: How to Avoid Succession Pitfalls and Create Valuable Exit Options , author Laurie Barkman provides a step-by-step process to ensure every business owner is prepared for this transition.

Key Points: 
  • In her new book, The Business Transition Handbook: How to Avoid Succession Pitfalls and Create Valuable Exit Options , author Laurie Barkman provides a step-by-step process to ensure every business owner is prepared for this transition.
  • It's crucial to start thinking three to five years in advance who might buy your business."
  • As a business exit planning advisor and host of the award-winning podcast Succession Stories , she provides guidance to business owners on how to plan successful transitions.
  • The Business Transition Handbook demystifies the exit process, guiding business owners who are considering leaving their ventures or beginning to think about their eventual next steps.

Alnylam Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Period Activity

Retrieved on: 
Thursday, May 4, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Genetics, Clinical Trials, HTRS, CHDI, Bachelor of Medicine, Bachelor of Surgery, Patisiran, PEG, Haemophilia, APOLLO, Acquisition, Patient, RNA interference, Cardiomyopathy, Brazilian Health Regulatory Agency, Polyneuropathy, The Lancet, Tissue, Therapy, NASH, Quarter, Corporate social responsibility, Brain, Medication, Randomness, Corporation, Liver, Growth, Innovation, Lancet, Viral hepatitis, Conference, Eos, Safety, ANVISA, Workplace, AHP, Hepatitis B virus, Truly Madly Deeply – Ultra Rare Tracks, Gene silencing, Shanda, Sanofi, HBV, Central nervous system, CER, Regeneron Pharmaceuticals, RTE, SAD, CNS, Peripheral nervous system, TTR, ATTR, Amyloidosis, Hemostasis, Pharmaceutical industry, Vaccine, Management, Cryptocurrency, Inclisiran, Alnylam Pharmaceuticals

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2023 and reviewed recent business highlights.

Key Points: 
  • Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2023 and reviewed recent business highlights.
  • Attained over 3,160 hATTR amyloidosis patients with polyneuropathy worldwide on commercial treatment with ONPATTRO or AMVUTTRA as of March 31, 2023.
  • Alnylam announces today that it intends to present 18-month results from the APOLLO-B Phase 3 study of patisiran at ESC-HF 2023, being held May 20-23, 2023 in Prague.
  • Financial Results for the Quarter Ended March 31, 2023

EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Business Update

Retrieved on: 
Tuesday, April 25, 2023
Vaccine, Operating cost, GSK, GMP, Omicron, CureVac COVID-19 vaccine, Civil service commission, European Molecular Biology Organization, COVID-19, Infection, Clinical trial, CureVac, Cancer, BMBF, PEG, CMOS, Temperature, CMO, Element, Federal Ministry of Health (Germany), Messenger, Trial of the century, Boehringer Ingelheim, EMBO, Patient, European, Melanoma, Epitope, Webcast, LNP, PD-1, CVAC, Therapy, WHO, EC, Virus, Education, European Commission, Safety, Fatigue, Cryptocurrency, Fine chemical, Pharmaceutical industry, Research

All candidates are based on CureVac’s proprietary second-generation mRNA backbone, targeting improved intracellular mRNA translation for early and strong immune responses.

Key Points: 
  • All candidates are based on CureVac’s proprietary second-generation mRNA backbone, targeting improved intracellular mRNA translation for early and strong immune responses.
  • On January 6 and January 30, 2023, CureVac announced positive preliminary data from ongoing Phase 1 clinical programs in COVID-19 and flu.
  • As of December 31, 2022, CureVac has settled most of its financial obligations related to CVnCoV.
  • In the first quarter of 2022, CureVac received a €10 million milestone payment related to the initiation of the seasonal flu clinical trial.

Technip Energies Announces the Launch of Its First Employee Share Offering ESOP 2023

Retrieved on: 
Tuesday, April 18, 2023
Oil, Gas, Manufacturing, Energy, Engineering, Utilities, PEG, Supervisory board, ESOP, Sale, Technip Energies, Euronext Paris, Prospectus, VWAP, ISIN, PEGI, Life insurance, Internet service provider, Security (finance), Medical device

Technip Energies (PARIS:TE) launches ESOP 2023, an employee share offering proposed to circa 12,000 eligible employees in 19 countries, with the objective of sharing the long-term value creation of the Group with employees.

Key Points: 
  • Technip Energies (PARIS:TE) launches ESOP 2023, an employee share offering proposed to circa 12,000 eligible employees in 19 countries, with the objective of sharing the long-term value creation of the Group with employees.
  • The offer is proposed as part of Technip Energies' Group Savings Plan (PEG) and International Group Savings Plan (PEGI).
  • It will be conducted via a share capital increase, up to the maximum of 1.5% of the share capital, within the limit of the total subscription amount of €30 million.
  • This press release does not constitute an offer to sell or an invitation to subscribe for Technip Energies shares.

PEG, LLC Earns 2023 ENERGY STAR® Sustained Excellence Award For Seventh Consecutive Year - Eleventh Overall

Retrieved on: 
Tuesday, March 28, 2023
U.S. Department of Energy, Office of Inspector General, Organization, EPA, PEG, Climate change, Environment, U.S. Department of Defense Strategy for Operating in Cyberspace, Sale, Public, Renewable energy, Recycling

FAIRFAX, Va., March 28, 2023 /PRNewswire/ -- PEG, LLC is proud to announce that it has received the 2023 ENERGY STAR Partner of the Year—Sustained Excellence Award from the U.S. Environmental Protection Agency and the U.S. Department of Energy for seventh consecutive year – eleventh overall.

Key Points: 
  • FAIRFAX, Va., March 28, 2023 /PRNewswire/ -- PEG, LLC is proud to announce that it has received the 2023 ENERGY STAR Partner of the Year—Sustained Excellence Award from the U.S. Environmental Protection Agency and the U.S. Department of Energy for seventh consecutive year – eleventh overall.
  • The Sustained Excellence award is the highest honor bestowed by the ENERGY STAR program.
  • ENERGY STAR award winners lead their industries in the production, sale, and adoption of energy-efficient products, homes, buildings, services, and strategies.
  • For a complete list of 2023 winners and more information about ENERGY STAR's awards program, visit energystar.gov/awardwinners.

Hardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth

Retrieved on: 
Thursday, March 16, 2023
AIC, Investment, EBITDA, PEG, NAV, Oakley, OCI, Growth, EV, Security (finance)

Hardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth

Key Points: 
  • Hardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
    The issuer is solely responsible for the content of this announcement.
  • The January trading statement announced NAV (662p per share), total NAV return (24%), NAV growth driven by EBITDA growth (65%), modest multiple expansion (35%), investments (£271m), realisations (£244m), available finance, including cash (£210m), and commitments (£929m).
  • Oakley adds value to its companies in all economic environments.
  • Its five-year share price total return (196%) is the best out of all the AIC investment companies.

Hardman & Co Research on Pantheon International Plc (PIN): Exceptional companies, long-term outperformance

Retrieved on: 
Saturday, March 11, 2023
EBITDA, Pantheon International, PEG, Growth, PIN, NAV, EV, Pharmaceutical industry

Hardman & Co Research on Pantheon International Plc (PIN): Exceptional companies, long-term outperformance

Key Points: 
  • Hardman & Co Research on Pantheon International Plc (PIN): Exceptional companies, long-term outperformance
    The issuer is solely responsible for the content of this announcement.
  • Hardman & Co Research on Pantheon International Plc:
    The November 2022 factsheet gave some key information, including the NAV (469.5p), NAV return (4%), net cash generation (£34m), distributions (£111.5m), calls (£77.5m), period-end cash (£52m) and commitments (£848m, including £303m new commitments).
  • We note that the PEG is 1.6x, around a fifth of the benchmark.
  • Please click on the link below for the full report:
    If you are interested in meeting the company, you can register your interest by clicking on the above link

For Consumer Protection Week, Get to Know the Telltale Signs of a Scam

Retrieved on: 
Tuesday, March 7, 2023
Bitcoin, PEG, ID, PIN, URL, NYSE, Customer, Long Island Power Authority, PSEG, Public Service Enterprise Group, National Consumer Agency, Address, Collection, Water, Panic, Online shopping, Mail, Sales, Cryptocurrency

UNIONDALE, N.Y., March 7, 2023 /PRNewswire/ -- This year, March 5-11 marks National Consumer Protection Week, and PSEG Long Island urges customers to understand scammers' tactics and do the right thing if confronted with a demand for payment and a threat of imminent shutoff: Get the truth from the real PSEG Long Island at 1-800-490-0025.

Key Points: 
  • "Consumer Protection Week is a time to help people understand their consumer rights and avoid frauds and scams.
  • More than 2,500 scam calls were reported to PSEG Long Island in 2022.
  • PSEG Long Island does not accept external, web-based electronic payment services (outside of payments through MyAccount) as a method of payment.
  • PSEG Long Island is a subsidiary of Public Service Enterprise Group Inc. (PSEG) (NYSE:PEG), a publicly traded diversified energy company.

PSE&G Proposes Third Phase of Gas System Modernization Program that Strengthens the State's Infrastructure and Sustains Thousands of Jobs

Retrieved on: 
Wednesday, March 1, 2023
Progress, Natural gas, Carbon, Climate change, Safety, Cooking, Edison Electric Institute, Transport, United Building & Construction Trades Council v. Mayor and Council of Camden, Gas, PSE, Climate, Dow Jones, NYSE, Methane, Workforce, Ageing, Partner, Commissioner, Middlesex County, Global warming potential, Public utility, New Jersey Board of Public Utilities, Mid-Atlantic (United States), PEG, Sulfur dioxide, Carbon monoxide, PSEG, GHG, J.D. Power, Investment, Hydrogen, Secretary of State of New Jersey, Pollutant, Heat, RNG, Wisconsin Board of Commissioners of Public Lands, EPA, Renewable energy, Rail transport

NEWARK, N.J., March 1, 2023 /PRNewswire/ -- PSE&G today filed for a three-year, $2.54 billion extension of its Gas System Modernization Program (GSMP) with the New Jersey Board of Public Utilities. The proposal would continue the utility's work to update its existing infrastructure to improve reliability and reduce greenhouse gas emissions (GHG) by replacing aged pipes with modern ones, and sustaining the thousands of jobs and skilled workforce created under GSMP II with the prospect of creating more jobs.

Key Points: 
  • The proposal also would introduce non-fossil alternatives, renewable natural gas (RNG) and hydrogen, into PSE&G's system.
  • PSE&G has won the ReliabilityOne® Award for superior electric system reliability in the Mid-Atlantic region for 21 consecutive years.
  • PSE&G received the 2022 ENERGY STAR® "Partner of the Year" award in the Energy Efficiency Program Delivery category, and J.D.
  • Power named PSE&G number one in customer satisfaction for both Residential Electric and Natural Gas Service in the East among Large Utilities.

Neighborhood Hotel Sells After Strategic Conversion and Rebranding as Apartments

Retrieved on: 
Wednesday, February 22, 2023
Creativity, Housing, AVIA, Acquisition, Highland Mall, PEG, LP, Sale, COVID-19, Cable television

Due to the hotel's apartment-like configuration, on-site amenities, and ideal neighborhood location in Austin, PEG ESCF purchased the property at a competitive price during the COVID-19 initial outbreak.

Key Points: 
  • Due to the hotel's apartment-like configuration, on-site amenities, and ideal neighborhood location in Austin, PEG ESCF purchased the property at a competitive price during the COVID-19 initial outbreak.
  • PEG ESCF credits the property's timely conversion and successful exit to PEG's vertically integrated structure and full-service capabilities.
  • PEG's entirely in-house conversion process begins with identifying the right hotel acquisition opportunities through the PEG Capital Partners division of the company.
  • The firm will launch another fund, geared toward the conversion of offices and hotels into multifamily, later this year.